Abstract:Background Reducing intestinal phosphorus absorption is a cornerstone in CKD-MBD management. Yet, knowledge gaps include how CKD pathophysiology affects intestinal phosphorus absorption. In vivo rodent studies suggest that intestinal phosphorus absorption remains inappropriately normal in early-moderate CKD, despite declining 1,25-dihydroxyvitamin D (1,25D). We measured intestinal phosphorus absorption in patients with moderate CKD versus healthy adults using a direct radiotracer method. Methods Patients with CKD and healthy adults matched for age, sex, and race were enrolled in this 8-day controlled diet study: the first 6 days outpatient and the final 2 days inpatient. Oral and intravenous doses of 33 P and serial blood and urine sampling determined intestinal phosphorus absorption during the final 2 days. Secondary outcomes included fasting biochemistries and 24-hour urine phosphorus (uP). Results In total, n =8 patients with CKD (eGFR=29–55 ml/min per 1.73 m 2 ) and n =8 matched healthy controls completed the study. On a controlled diet, no difference in fractional intestinal phosphorus absorption was detected between patients with CKD and healthy adults (0.69 versus 0.62, respectively; P =0.52), and this was similar for 24-hour uP (884 versus 935 mg/d, respectively; P =0.70). Fractional intestinal phosphorus absorption was not significantly related to 24-hour uP. Patients with CKD had higher serum intact PTH and intact FGF23 and lower 1,25D. The relationship between 1,25D and fractional intestinal phosphorus absorption was not statistically significant. Conclusions Intestinal phosphorus absorption with typical dietary intake did not differ in patients with moderate CKD compared with controls, despite lower serum 1,25D levels. In this setting, a relationship between 24-hour uP and fractional or absolute intestinal absorption was not evident. Further investigation is needed to determine what factors influence intestinal phosphorus absorption in CKD and the apparent lack of compensation by the intestine to limit phosphorus absorption in the face of declining kidney function and reduced 1,25D. Whether this is evident across a range of dietary phosphorus intakes, as well as CKD severity, also needs to be determined. Clinical Trial registry name and registration number: Phosphorus Absorption in Healthy Adults and in Patients with Moderate Chronic Kidney Disease, NCT03108222 Significance Statement Reducing intestinal phosphorus absorption through dietary restrictions and phosphate binders is common in managing and preventing CKD-MBD. Yet, how CKD pathophysiology affects intestinal phosphorus absorption is poorly understood. This study determined intestinal phosphorus absorption in patients with moderate CKD compared with healthy adults using a direct 33 P radiotracer method in a controlled feeding study setting. Intestinal phosphorus absorption with dietary intake typical for the general population is not detectably different in patients with moderate CKD compared with control subjects, despite lower 1,25-dihydroxyvitamin D levels. These human data corroborate recent findings in CKD rat models. Understanding which factors influence intestinal phosphorus absorption in patients with CKD—particularly the apparent lack of intestinal compensation in the context of declining kidney function and reduced 1,25-dihydroxyvitamin D—will better inform approaches to reduce phosphorus absorption and prevent CKD-MBD in patients with CKD. Visual

The absorption of dietary phosphorus and calcium in hemodialysis patients

Acute effects of dietary phosphorus intake on markers of mineral metabolism in hemodialysis patients: post hoc analysis of a randomized crossover trial

Intestinal Phosphorus Absorption in Moderate CKD and Healthy Adults Determined Using a Radioisotopic Tracer

Postprandial Mineral Handling in Patients on Maintenance Hemodialysis

Daily Dietary Phosphorus Intake Variability and Hemodialysis Patient Adherence to Phosphate Binder Therapy.

Relationship between Gut Microbiota and Phosphorus Metabolism in Hemodialysis Patients: A Preliminary Exploration

Calcium and Phosphorus Balance in Chinese Continuous Ambulatory Peritoneal Dialysis Patients

Intestinal Phosphorus Absorption in Chronic Kidney Disease

Calcium Effects on Phosphorus Absorption: Implications for the Prevention and Co-Therapy of Osteoporosis

Dietary Phosphorus Intake and Distribution in Chinese Peritoneal Dialysis Patients with and Without Hyperphosphatemia

Relationship between dietary phosphorus intake and nutritional status and calcium and phosphorus metabolism in patients with chronic kidney disease

Randomized Controlled Trial of Dialysate Calcium Concentrations on Risks of Adverse Reactions in Hemodialysis Patients During Dialysis

Mineral and Bone Disorder in Chinese Dialysis Patients: a Multicenter Study

Influence of Low Calcium Dialysate on Serum Parathyroid Hormone, Calcium and Phosphate in Patients under Hemodialysis

The present status and the related factors of abnormal calcium- phosphorous metabolism in mainte-nance hemodialysis patients

Phosphorus Knowledge and Dietary Intake of Phosphorus of US Adults Undergoing Dialysis

Influence of the Application of Low-Calcium Dialysate in Combination with Calcitriol in Serum Calcium-Phosphorus Levels

A study of combination therapy for hyperphosphatemia with calcium-containing phosphate binders and low-calcium dialysate in hemodialysis patients.

Abnormal factors analysis of calcium-phosphorus metabolism disorder in maintenance hemodialysis patients

Effects of Reduced Dialysate Calcium on Calcium-Phosphorus Product and Bone Metabolism in Hemodialysis Patients